Pharmaceutical Grade Milbemycin Oxime for Internal & External Parasites CAS 129496-10-2

Name: Pharmaceutical Grade Milbemycin Oxime for Internal & External Parasites CAS 129496-10-2
Brand: Hubei Vanz Pharm Co., Ltd.
SKU: 2152030505

Hubei, ChinaHubei Vanz Pharm Co., Ltd.

US$15.00-40.00

1 gram

Product profile

Customization

Available

Resource

Chemosynthesis

Powder

Yes

Model NO.

Milbemycin Oxime

Customized

Non-Customized

Certification

Hse, ISO 9001, USP, Bp

State

Solid

Suitable for

Research Purpose Only

Purity

Not Less Than 99%

Stock

in Stock

Documents

COA, MSDS

MOQ

CAS

129496-10-2

Transport Package

Box/Drum

Specification

99%

Trademark

VANZ

Origin

China

Production Capacity

2000kg/Month

Company profile

High Repeat Buyers ChoiceYears of Export ExperienceExperienced TeamFast Delivery

Hubei Vanz Pharm Co., Ltd.

Hubei, China

Business Type: Manufacturer/FactoryExport Year: 2013-01-01Nearest Port: shanghaiAverage Response Time: ≤6.26hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, FAS, FCA

AI-Powered supplier vetting

SummaryThe supplier is identified as a factory in Jiayu County, Hubei, producing pharmaceutical intermediates with stated annual productivity of 40 tons. It reports ISO 9001 certification, documented service-assessment, corrective-action, and customer-complaint procedures, and export capability covering multiple regions. Its capabilities include sample-based customization, ODM, and OEM services, while it does not provide 3D software design, has no available SDK, and reported no new products in the past year. The company description states that it has completed R&D for more than 20 APIs and intermediates and operates several laboratories, although other records classify it as not being a professional technical supplier. Overseas warehouses, showrooms, agents or branches, and offline trade-show participation are not available. Customer-specific cases are not explicitly provided.

Supplier typeThe supplier is explicitly identified as a factory, with pharmaceutical intermediates as its stated product and annual productivity of 40 tons. It also holds self-operated import and export rights, indicating manufacturing and direct export capability.

CertificationsThe supplier reports ISO 9001 certification for its management system. This is explicit evidence of holding a recognized quality-management certification.

After-Sales capabilityThe supplier has written and followed procedures for service assessment, corrective and preventive actions, and customer complaints. However, it lacks overseas warehouses, showrooms, agents or branches, and has not participated in offline trade shows, so the evidence supports formal service processes but not broad overseas service coverage.

Production capacityThe supplier is a factory producing pharmaceutical intermediates with stated annual productivity of 40 tons, 6–10 quality-control staff, and stated order fulfillment within 15 working days in both peak and off-peak seasons. These records explicitly support production capability and operational capacity.

Customization capabilityThe supplier provides customization from samples and reports both ODM and OEM services, including services for popular brands. These explicit offerings demonstrate customization and outsourced design/manufacturing capability, although no 3D software design service or SDK is available.